Page last updated: 2024-10-26

distigmine and Parkinson Disease, Secondary

distigmine has been researched along with Parkinson Disease, Secondary in 1 studies

distigmine : A carbamate ester resulting from the formal condensation of both carboxy groups of hexane-1,6-diylbis(methylcarbamic acid) with the hydroxy group of 3-hydroxy-1-methylpyridinium.

Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)

Research Excerpts

ExcerptRelevanceReference
"A 74-year-old man became unable to walk two days following the initiation of administration of oral distigmine bromide, 10 mg per day, for his constipation."3.73[Distigmine bromide induced Parkinsonism. A case report]. ( Nakahara, T; Nakamura, K; Sato, S; Yamamoto, T, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sato, S1
Nakamura, K1
Nakahara, T1
Yamamoto, T1

Other Studies

1 other study available for distigmine and Parkinson Disease, Secondary

ArticleYear
[Distigmine bromide induced Parkinsonism. A case report].
    Rinsho shinkeigaku = Clinical neurology, 2005, Volume: 45, Issue:8

    Topics: Aged; Constipation; Humans; Male; Parkinson Disease, Secondary; Pyridinium Compounds

2005